Royce & Associates LP Has $9.55 Million Stock Holdings in AdaptHealth Corp. (NASDAQ:AHCO)

Royce & Associates LP boosted its position in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 29.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,002,755 shares of the company's stock after acquiring an additional 225,350 shares during the quarter. Royce & Associates LP owned 0.75% of AdaptHealth worth $9,546,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Principal Financial Group Inc. raised its holdings in shares of AdaptHealth by 39.7% in the 3rd quarter. Principal Financial Group Inc. now owns 543,744 shares of the company's stock valued at $6,106,000 after purchasing an additional 154,434 shares during the period. Victory Capital Management Inc. increased its position in AdaptHealth by 727.4% during the third quarter. Victory Capital Management Inc. now owns 141,507 shares of the company's stock worth $1,589,000 after buying an additional 124,404 shares during the last quarter. Oppenheimer Asset Management Inc. raised its stake in AdaptHealth by 33.8% in the third quarter. Oppenheimer Asset Management Inc. now owns 27,814 shares of the company's stock valued at $312,000 after buying an additional 7,031 shares during the period. CIBC Asset Management Inc acquired a new stake in shares of AdaptHealth in the third quarter valued at approximately $122,000. Finally, Mutual of America Capital Management LLC boosted its stake in shares of AdaptHealth by 23.8% during the 3rd quarter. Mutual of America Capital Management LLC now owns 15,893 shares of the company's stock worth $178,000 after acquiring an additional 3,052 shares during the period. Institutional investors and hedge funds own 82.67% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on AHCO shares. Truist Financial raised their target price on shares of AdaptHealth from $12.00 to $14.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Robert W. Baird raised their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an "outperform" rating in a research report on Thursday, February 27th. Canaccord Genuity Group upped their target price on AdaptHealth from $13.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Royal Bank of Canada lifted their price target on AdaptHealth from $11.00 to $14.00 and gave the stock an "outperform" rating in a report on Wednesday, February 26th. Finally, UBS Group decreased their price objective on AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a report on Thursday, February 13th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $13.80.

AdaptHealth Price Performance

Shares of NASDAQ:AHCO traded down $0.02 during trading on Friday, reaching $9.99. 8,999,438 shares of the company traded hands, compared to its average volume of 1,153,941. The firm has a market capitalization of $1.35 billion, a PE ratio of -6.05, a PEG ratio of 1.08 and a beta of 1.30. The company's 50 day moving average is $10.01 and its two-hundred day moving average is $10.19. AdaptHealth Corp. has a 52 week low of $8.35 and a 52 week high of $11.90. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.